Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Asthma/Airway Disease Rsch Ctr
29 active people
33 grants
Recent Grants
A Role for Pharmaceutical Control of Protease-activated Receptor-2 for the Treatment of Asthma
2024
·
$716.7K
pharmaceutical control,
protease-activated receptor-2,
asthma treatment,
role of protease,
drug therapy
Breathing Easier in Schools: Enhancing Adoption, Fidelity, and Effectiveness of the SAFE School Program through Innovation Implementation Strategies (School in place of Albuterol)
2024
·
$714.6K
school health,
innovative implementation,
respiratory health,
education programs,
implementation science
Defining Mechanisms Of Cc16 On Epithelial-driven Host Responses To Pathogens
2024
·
$606.4K
lung inflammation,
host-pathogen interaction,
epithelial cells,
immune response,
biomarker
Empowering Communities: Amplifying the Reach of the Stock Inhaler for Schools Program in Rural Counties and Tribal Nations through Strategic Partnerships
2024
·
$380K
community health,
strategic partnerships,
rural healthcare,
school health,
tribal healthcare
Creatine Kinase in the Natural History of Asthma
2024
·
$231.6K
asthma,
creatine kinase,
natural history,
biomarkers,
inflammation
Therapeutics Development Center Award
2024
·
$150.5K
therapeutics,
development,
award
A Multicentre, Randomised, Double-blind, Parallel Group,Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eos
2023
·
$2.9M
asthma,
pediatric patients,
clinical trial,
drug treatment
CFF Data and Safety Monitoring Board
2023
·
$1.1M
clinical trials,
data monitoring,
safety,
healthcare regulation,
medical ethics
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Study to Assess the Efficacy and Safety of Daily OM-85 Treatment Versus Placebo Given on Top of Standard of Care in Children Aged
2023
·
$814.9K
clinical trial,
immunotherapy,
pediatric medicine,
respiratory health,
drug efficacy
A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous lmmunotherapy with DBV712 250 ?g in 4-7-year-old Children with Peanut Allergy (VITESSE)
2023
·
$397.9K
immunotherapy,
peanut allergy,
efficacy,
safety,
children
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF (STRONG-CF)
2023
·
$292K
nutrition,
lung function,
muscle strength,
cystic fibrosis,
outcomes
A Randomised, Double-blind, Parallel Group Phase III Study To Assess The Efficacy And Safety Of 100 Mg Sc Depemokimab In Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Anchor 2 Depem
2023
·
$203.2K
chronic rhinosinusitis,
nasal polyps,
efficacy,
safety
Development of Small Molecule Antagonists of PAR2 for Oral Treatment of Asthma
2023
·
$154.4K
asthma,
drug development,
small molecule,
oral treatment
A Phase I Clinical Trial to Evaluate the Safety and Tolerability of VLP Peanut in Healthy Subjects and Subjects With Peanut Allergy and to Explore Preliminary Signals of Its Efficacy (PROTECT)
2023
·
$137.8K
clinical trials,
peanut allergy,
vaccine,
safety,
efficacy
Standardizing Treatments for Pulmonary Exacerbations: A platform for evaluating treatment decisions to improve outcomes (STOP360)
2023
·
$125.2K
pulmonary exacerbations,
treatment standardization,
evaluation platform,
treatment decisions,
outcomes improvement
Food Allergy patient Samples (OATS)
2023
·
$61.1K
food allergy,
patient samples,
oats,
medical research,
immunology
Innovations for Home Spirometry Implementation in Youth with Cystic Fibrosis (I-SPY)
2023
·
$38.1K
home spirometry,
cystic fibrosis,
innovations,
youth,
implementation
Development of SP-A-Derived Peptidomimetics for the Treatment of Asthma - Phase II
2022
·
$1M
peptidomimetics,
asthma,
sp-a-derived,
treatment,
development
Therapeutics Development Center Award
2022
·
$334.1K
therapeutics,
development,
center,
award,
medical research
Innate Immunity and Viral Infection in Asthma
2021
·
$5.7M
innate immunity,
viral infection,
asthma,
immune response,
respiratory health
People
Ashley Michael
Research Technologist II
Amber Spangenberg
Research Specialist, Principal
Elizabeth Firmage
Administrative Operations Manager IV
Elvira Begay
Research Professional I
Bruce Saul
Database Administrator II
Clara Ehrman
Research Program Administration Officer I
Dayna Anderson
Research Technologist II
Debra Stern
Data Scientist Manager III
Destiny Hessel
Research Technician II
Eva Barrow
Administrative Support Assistant II
Elia Cornidez
Clinical Research Coordinator III
Elizabeth Ryan
Clinical Research Coordinator IV
Gabriel Camacho
Clinical Research Coordinator IV
David Spies
Applications Systems Analyst/Developer, Senior
Erin Cool
Accounting Manager I
Hyunjin Kang
Research Professional II
Jaesa Strong
Research Compliance Administrator III
Janell Merchen
Nurse Practitioner III
Leslie Hargrove
Research Program Administration Officer III
Michele Simon
Grant and Contract Administrator II
Meg Rother-Gossmann
Administrative Support Professional II
Megan Peterson
Research Nurse II
Nirushan Narendran
Clinical Research Coordinator III
Osmara Molina de Rodriguez
Clinical Research Manager II
Oksana Pivniouk
Research Laboratory Manager I
Sheilah Allison
Research Technician III
Seongmin Hahn
Research Technologist II
Silvia Lopez
Research Nurse III
Zachary Stetson
App Develop Prgmer Analyst I
